Cardiovascular Effects of Selective I(f)-Channel Blockade

NCT00865917 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Postural Orthostatic Tachycardia Syndrome

Interventions

DRUG: beta-blocker (Metoprolol)
DRUG: I(f)-blocker (ivabradine)
DRUG: Placebo

Sponsor

Hannover Medical School

Collaborators

[object Object]